Riskpilot← Back to searchSign inGet full accessdocR kliniken AB
ABActiveOrg 5592154875Fristorp 250Beauty care and other beauty treatment activities · NACE 9622Est. 20190 employees
Revenue 2024
SEK 313K
-6% vs 2023
EBITDA margin
6.7%
-5% vs 2023
Equity ratio
48.3%
Financial strength
Net profit 2024
SEK 17K
-15% vs 2023
| Revenue | SEK 313K | -6% |
| EBITDA | SEK 21K | -5% |
| Net profit | SEK 17K | -15% |
| Total assets | SEK 151K | +36% |
| Equity | SEK 73K | +28% |
| Employees | 0 | — |
Legal name
docR kliniken AB
Org number
5592154875
Legal form
Aktiebolag
NACE code
9622 · Beauty care and other beauty treatment activities
Founded
21 augusti 2019
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva estetisk injektionsbehandling och mindre kirurgiska ingrepp, samt konsultation tillhörande detta i privat mottagning. Utbildning och medicinsk rådgivning och därmed förenlig verksamhet.
Address
Fristorp 250
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 64 | 126 | 334 | 313 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −3 | −14 | 5 | 22 | 21 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −3 | −14 | 5 | 22 | 21 |
| Net financials | — | −1 | — | — | — |
| Profit before tax | −3 | −15 | 5 | 22 | 21 |
| Tax | −0 | −0 | −0 | −2 | −4 |
| Net profit | −3 | −15 | 5 | 20 | 17 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 48 | 64 | 60 | 111 | 151 |
| Equity | 47 | 32 | 37 | 57 | 73 |
| Long-term debt | 2 | 18 | 13 | 10 | 18 |
| Short-term debt | 0 | 14 | 10 | 44 | 60 |
| Total debt | 2 | 32 | 23 | 54 | 78 |
EBITDA margin
6.7%
This company
15.8%
Market median
-58% vs market
20202024
Equity ratio
48.3%
This company
38.2%
Market median
+26% vs market
20202024
Return on equity
23.3%
This company
18.4%
Market median
+27% vs market
20202024
Net profit margin
5.4%
This company
8.1%
Market median
-33% vs market
20202024
Asset turnover
2.07×
This company
1.12×
Market median
+85% vs market
20202024
Debt / equity
1.07×
This company
0.62×
Market median
-73% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-08-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
UR Authorized Recipient of Service | Authorized Recipient of Service | 2024 |
HR Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of docR kliniken AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Urszula Rasoul-Mahdi | Authorized Recipient of Service | 0 companies |
| Haidar Rasoul Mahdi | Chief Executive Officer | 0 companies |
| Hasan Rasoul Mahdi | Deputy Board Member | 0 companies |